MBIRX
Price
$60.52
Change
+$0.51 (+0.85%)
Updated
Sep 4 closing price
Net Assets
1.55B
RGEBX
Price
$82.44
Change
+$0.19 (+0.23%)
Updated
Sep 5 closing price
Net Assets
331.65B
Interact to see
Advertisement

MBIRX vs RGEBX

Header iconMBIRX vs RGEBX Comparison
Open Charts MBIRX vs RGEBXBanner chart's image
Morgan Stanley Insight IR
Price$60.52
Change+$0.51 (+0.85%)
VolumeN/A
Net Assets1.55B
American Funds Growth Fund of Amer R2E
Price$82.44
Change+$0.19 (+0.23%)
VolumeN/A
Net Assets331.65B
MBIRX vs RGEBX Comparison Chart in %
Loading...
View a ticker or compare two or three
VS
MBIRX vs. RGEBX commentary
Sep 07, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is MBIRX is a Buy and RGEBX is a Buy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
RGEBX has more cash in the bank: 332B vs. MBIRX (1.55B). MBIRX pays higher dividends than RGEBX: MBIRX (0.54) vs RGEBX (0.00). MBIRX was incepted earlier than RGEBX: MBIRX (6 years) vs RGEBX (11 years). MBIRX (14.61) is less costly to investors than RGEBX (1.09). MBIRX is a more actively managed with annual turnover of: 44.00 vs. RGEBX (25.00). RGEBX has a lower initial minimum investment than MBIRX: RGEBX (250) vs MBIRX (10000000). MBIRX annual gain was more profitable for investors over the last year : 75.67 vs. RGEBX (17.59). RGEBX return over 5 years is better than : 38.71 vs. MBIRX (-24.22).
MBIRXRGEBXMBIRX / RGEBX
Total Expense Ratio0.851.0978%
Annual Report Gross Expense Ratio14.611.091,340%
Fund Existence6 years11 years-
Gain YTD24.34815.398158%
Front LoadN/AN/A-
Min. Initial Investment100000002504,000,000%
Min. Initial Investment IRAN/AN/A-
Net Assets1.55B332B0%
Annual Yield % from dividends0.540.00-
Returns for 1 year75.6717.59430%
Returns for 3 years69.6657.61121%
Returns for 5 years-24.2238.71-63%
Returns for 10 yearsN/A91.44-
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
ARTV3.610.50
+16.08%
Artiva Biotherapeutics Inc
DNLI15.430.64
+4.33%
Denali Therapeutics
DOCS69.340.82
+1.20%
Doximity
SNDA25.80-0.03
-0.12%
Sonida Senior Living
CETX0.89N/A
-0.12%
Cemtrex In